Theralase Technologies's market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is -7.93; Theralase Technologies is scheduled to report earnings on May 29, 2024, and the estimated EPS forecast is C$0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	C$ 280.61K	C$ 218.93K	C$ 207.16K	C$ 325.57K	C$ 260.56K
Gross Profit	C$ 141.67K	C$ 108.62K	C$ 92.52K	C$ 204.41K	C$ 142.98K
EBIT	C$ -1.01M	C$ -1.15M	C$ -1.40M	C$ -874.33K	C$ -1.41M
EBITDA	C$ -936.39K	C$ -1.08M	C$ -1.33M	C$ -795.45K	C$ -1.32M
Net Income Common Stockholders	C$ -1.02M	C$ -1.16M	C$ -1.41M	C$ -883.20K	C$ -1.40M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 482.46K	C$ 603.69K	C$ 533.47K	C$ 1.65M	C$ 2.55M
Total Assets	C$ 3.00M	C$ 3.38M	C$ 3.20M	C$ 4.16M	C$ 4.91M
Total Debt	C$ 409.14K	C$ 431.01K	C$ 452.50K	C$ 473.62K	C$ 487.45K
Net Debt	C$ -73.33K	C$ -172.68K	C$ -80.97K	C$ -1.18M	C$ -2.06M
Total Liabilities	C$ 1.37M	C$ 1.34M	C$ 1.35M	C$ 1.07M	C$ 4.91M
Stockholders Equity	C$ 1.63M	C$ 2.04M	C$ 1.85M	C$ 3.09M	C$ 3.66M
Cash Flow	-
Free Cash Flow	C$ -605.33K	C$ -1.13M	C$ -1.12M	C$ -1.17M	C$ -4.04M
Operating Cash Flow	C$ -594.42K	C$ -1.12M	C$ -1.11M	C$ -1.10M	C$ -4.03M
Investing Cash Flow	C$ -10.91K	C$ -3.05K	C$ -11.87K	C$ -63.32K	C$ -7.09K
Financing Cash Flow	C$ 433.12K	C$ 1.17M	C$ -21.87K	C$ 226.28K	C$ 2.79M

Currency in CAD

Theralase Technologies Earnings and Revenue History

Income Statement >

Theralase Technologies Debt to Assets

Balance Sheet >

Theralase Technologies Cash Flow

Cash Flow >

Theralase Technologies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing